Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
4.870
+0.050 (1.04%)
At close: Aug 7, 2026, 4:00 PM EDT
4.700
-0.170 (-3.49%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $47.16 million as of August 7, 2026. Its market cap has decreased by -60.93% in one year.
Market Cap
47.16M
Enterprise Value
88.21M
1-Year Change
-60.93%
Ranking
Category
Stock Price
$4.87
ChartMarket Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $47.16M, a decrease of -97.50%. That is a compound annual growth rate of -28.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 48.40M | -64.04% |
| Dec 31, 2025 | 134.60M | -5.14% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
| Jun 26, 2015 | 1.88B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 50.25M |
| Veraxa Biotech AG | 50.18M |
| aTyr Pharma | 50.14M |
| Immutep | 49.96M |
| Filana Therapeutics | 48.07M |
| Karyopharm Therapeutics | 48.05M |
| Mereo BioPharma Group | 47.29M |
| Impact BioMedical | 46.91M |